These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17884238)

  • 1. PEGylation of cyanovirin-N, an entry inhibitor of HIV.
    Zappe H; Snell ME; Bossard MJ
    Adv Drug Deliv Rev; 2008 Jan; 60(1):79-87. PubMed ID: 17884238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
    Mori T; Shoemaker RH; Gulakowski RJ; Krepps BL; McMahon JB; Gustafson KR; Pannell LK; Boyd MR
    Biochem Biophys Res Commun; 1997 Sep; 238(1):218-22. PubMed ID: 9299482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
    Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).
    Gandhi MJ; Boyd MR; Yi L; Yang GG; Vyas GN
    Dev Biol (Basel); 2000; 102():141-8. PubMed ID: 10794101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro.
    Wang JH; Tam SC; Huang H; Ouyang DY; Wang YY; Zheng YT
    Biochem Biophys Res Commun; 2004 May; 317(4):965-71. PubMed ID: 15094363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum.
    Gustafson KR; Sowder RC; Henderson LE; Cardellina JH; McMahon JB; Rajamani U; Pannell LK; Boyd MR
    Biochem Biophys Res Commun; 1997 Sep; 238(1):223-8. PubMed ID: 9299483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium.
    Mori T; Gustafson KR; Pannell LK; Shoemaker RH; Wu L; McMahon JB; Boyd MR
    Protein Expr Purif; 1998 Mar; 12(2):151-8. PubMed ID: 9518455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.
    Buffa V; Stieh D; Mamhood N; Hu Q; Fletcher P; Shattock RJ
    J Gen Virol; 2009 Jan; 90(Pt 1):234-43. PubMed ID: 19088294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
    Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM
    Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.
    Hu J; Duppatla V; Harth S; Schmitz W; Sebald W
    Bioconjug Chem; 2010 Oct; 21(10):1762-72. PubMed ID: 20886828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy.
    Barrientos LG; Gronenborn AM
    Mini Rev Med Chem; 2005 Jan; 5(1):21-31. PubMed ID: 15638789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed enzymatic PEGylation of the human granulocyte colony-stimulating factor.
    Maullu C; Raimondo D; Caboi F; Giorgetti A; Sergi M; Valentini M; Tonon G; Tramontano A
    FEBS J; 2009 Nov; 276(22):6741-50. PubMed ID: 19843182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiviral lectin cyanovirin-N: probing multivalency and glycan recognition through experimental and computational approaches.
    Woodrum BW; Maxwell JD; Bolia A; Ozkan SB; Ghirlanda G
    Biochem Soc Trans; 2013 Oct; 41(5):1170-6. PubMed ID: 24059504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity.
    Cazalis CS; Haller CA; Sease-Cargo L; Chaikof EL
    Bioconjug Chem; 2004; 15(5):1005-9. PubMed ID: 15366953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
    Chang LC; Lee HF; Chung MJ; Yang VC
    Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent.
    Huskens D; Vermeire K; Vandemeulebroucke E; Balzarini J; Schols D
    Int J Biochem Cell Biol; 2008; 40(12):2802-14. PubMed ID: 18598778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.
    Mero A; Spolaore B; Veronese FM; Fontana A
    Bioconjug Chem; 2009 Feb; 20(2):384-9. PubMed ID: 19186937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.